Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Variable

n = 331 (100%)

Age (year)

 Mean (SD)

55.33 (10.01)

 Median (range)

56 (19, 73)

Sex, n (%)

 Female

129 (39.0)

 Male

202 (61.0)

Race, n (%)

 American Indian or Alaska Native

1 (0.3)

 Asian

2 (0.6)

 Black or African American

7 (2.1)

 Hispanic or Latino

16 (4.8)

 White

294 (88.8)

 Not availablea

11 (3.3)

KPS at baseline, n (%)

 < 90

97 (29.3)

 ≥ 90

234 (70.7)

MGMT classification, n (%)

 Methylated

131 (39.6)

 Not methylated

162 (48.9)

 Not available

38 (11.5)

Lymphocyte group, n (%)

 High

161 (48.6)

 Low

170 (51.4)

Surgical status, n (%)

 Partial resection

122 (36.9)

 Complete resection

209 (63.1)

  1. aRace is in some cases not collected due to institutional policy